Antimicrobial Agents and Chemotherapy

It’s vital to optimize use of antimicrobials Optimize antimicrobial use to confirm effectiveness whereas minimizing resistance development in common community-acquired infections Identify management ways to stop, or minimize clinically important drug interactions with common antimicrobials. Safety and effectiveness of intravenous iron in patients with chemotherapyelicited anaemia receiving darbepoetin alpha Effects of endogenous (IV) iron supplementation on responses to every-three-week (Q3W) darbepoetin alpha (DA) by baseline haemoglobin in patients (pts.) with chemotherapy-induced anemia (CIA)1 A phase III clinical trial randomised controlled study comparison iron saccharose intravenously (IV) to no iron treatment of anemia in cancer patients undergoing therapy and glycoprotein stimulating agent (ESA) therapy Improvement in quality of life precedes increase in haemoglobin levels upon treatment with intravenous iron and epoetin alpha.

 

    Related Conference of Antimicrobial Agents and Chemotherapy

    September 06-07, 2021

    11th World Congress on Rare Diseases and Orphan Drugs

    Berlin, Germany
    September 13-14, 2021

    4th Global Experts Meeting on Infectious Diseases

    Singapore City, Singapore
    October 21-22, 2021

    International Conference on Tropical Diseases and Cure

    Zurich, Switzerland
    November 22-23, 2021

    3rd World Congress on Advancements in Tuberculosis and Lung Diseases

    Singapore City, Singapore
    December 28-28, 2021

    11th European Epidemiology and Public Health Congress

    Paris, France
    February 07-08, 2022

    9th International Congress on Infectious Diseases

    Aberdeen, UK

    Antimicrobial Agents and Chemotherapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in